[96a5a0]: / output / allTrials / identified / NCT01703091_identified.json

Download this file

502 lines (502 with data), 21.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
{
"info": {
"nct_id": "NCT01703091",
"official_title": "A Randomized, Double-Blind, Phase 2 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Prior Platinum-Based Therapy",
"inclusion_criteria": "* Non-Small Cell Lung Cancer disease\n* Clinical stage IV or recurrent disease\n* One prior first-line platinum-based chemotherapy regimen with or without maintenance therapy\n* For Non-Small Cell Lung Cancer (NSCLC) tumors other than squamous cell histology, the epidermal growth factor receptor (EGFR) mutation status is known prior to randomization\n* For participants with activating epidermal growth factor receptor (EGFR) mutation only, prior epidermal growth factor receptor- tyrosine kinase inhibitor (EGFR-TKI) monotherapy (only one regimen in the setting of single use) should be utilized\n* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1\n* Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version RECIST version 1.1\n* Adequate organ function\n* Estimated life expectancy of at least 3 months.\nHealthy volunteers allowed\nMust have minimum age of 20 Years",
"exclusion_criteria": "* Have undergone major surgery within 28 days prior to randomization or have planned major surgery during study treatment\n* Receiving concurrent treatment with other anticancer therapy\n* Central nervous system disease other than stable and treated brain metastasis\n* Has major blood vessel invasion or encasement by cancer\n* Has intratumor cavitation\n* Has a history of uncontrolled thrombotic disorder\n* Is receiving therapeutic anticoagulation with drugs\n* Is receiving chronic therapy with nonsteroidal anti-inflammatory drugs\n* Has a history of hemoptysis within 2 months prior to randomization\n* Has clinically relevant congestive heart failure\n* Has experienced any arterial thromboembolic event\n* Has uncontrolled arterial hypertension\n* Has had a serious or nonhealing wound or, ulcer\n* Has significant existing conditions",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Non-Small Cell Lung Cancer disease",
"criterions": [
{
"exact_snippets": "Non-Small Cell Lung Cancer",
"criterion": "Non-Small Cell Lung Cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Clinical stage IV or recurrent disease",
"criterions": [
{
"exact_snippets": "Clinical stage IV",
"criterion": "clinical stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IV"
}
]
},
{
"exact_snippets": "recurrent disease",
"criterion": "disease recurrence",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* One prior first-line platinum-based chemotherapy regimen with or without maintenance therapy",
"criterions": [
{
"exact_snippets": "One prior first-line platinum-based chemotherapy regimen",
"criterion": "prior chemotherapy regimen",
"requirements": [
{
"requirement_type": "type",
"expected_value": "platinum-based"
},
{
"requirement_type": "line",
"expected_value": "first-line"
},
{
"requirement_type": "quantity",
"expected_value": true
}
]
},
{
"exact_snippets": "with or without maintenance therapy",
"criterion": "maintenance therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "optional"
}
]
}
]
},
{
"line": "* For Non-Small Cell Lung Cancer (NSCLC) tumors other than squamous cell histology, the epidermal growth factor receptor (EGFR) mutation status is known prior to randomization",
"criterions": [
{
"exact_snippets": "Non-Small Cell Lung Cancer (NSCLC) tumors other than squamous cell histology",
"criterion": "NSCLC tumor histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "non-squamous"
}
]
},
{
"exact_snippets": "epidermal growth factor receptor (EGFR) mutation status is known prior to randomization",
"criterion": "EGFR mutation status",
"requirements": [
{
"requirement_type": "knowledge",
"expected_value": true
}
]
}
]
},
{
"line": "* For participants with activating epidermal growth factor receptor (EGFR) mutation only, prior epidermal growth factor receptor- tyrosine kinase inhibitor (EGFR-TKI) monotherapy (only one regimen in the setting of single use) should be utilized",
"criterions": [
{
"exact_snippets": "activating epidermal growth factor receptor (EGFR) mutation",
"criterion": "EGFR mutation",
"requirements": [
{
"requirement_type": "type",
"expected_value": "activating"
}
]
},
{
"exact_snippets": "prior epidermal growth factor receptor- tyrosine kinase inhibitor (EGFR-TKI) monotherapy",
"criterion": "EGFR-TKI monotherapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
},
{
"exact_snippets": "only one regimen in the setting of single use",
"criterion": "EGFR-TKI monotherapy regimen",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "regimen"
}
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0 or 1",
"criterion": "ECOG Performance Status",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version RECIST version 1.1",
"criterions": [
{
"exact_snippets": "Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version RECIST version 1.1",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "definition",
"expected_value": "Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1"
}
]
}
]
},
{
"line": "* Adequate organ function",
"criterions": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Estimated life expectancy of at least 3 months.",
"criterions": [
{
"exact_snippets": "Estimated life expectancy of at least 3 months.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 20 Years",
"criterions": [
{
"exact_snippets": "minimum age of 20 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Have undergone major surgery within 28 days prior to randomization or have planned major surgery during study treatment",
"criterions": [
{
"exact_snippets": "Have undergone major surgery within 28 days prior to randomization",
"criterion": "major surgery",
"requirements": [
{
"requirement_type": "time since surgery",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
]
},
{
"exact_snippets": "have planned major surgery during study treatment",
"criterion": "planned major surgery",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "during study treatment"
}
]
}
]
},
{
"line": "* Receiving concurrent treatment with other anticancer therapy",
"criterions": [
{
"exact_snippets": "Receiving concurrent treatment with other anticancer therapy",
"criterion": "concurrent anticancer therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Central nervous system disease other than stable and treated brain metastasis",
"criterions": [
{
"exact_snippets": "Central nervous system disease other than stable and treated brain metastasis",
"criterion": "central nervous system disease",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": "other than stable and treated brain metastasis"
}
]
}
]
},
{
"line": "* Has major blood vessel invasion or encasement by cancer",
"criterions": [
{
"exact_snippets": "major blood vessel invasion",
"criterion": "major blood vessel invasion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "encasement by cancer",
"criterion": "encasement by cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has intratumor cavitation",
"criterions": [
{
"exact_snippets": "Has intratumor cavitation",
"criterion": "intratumor cavitation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has a history of uncontrolled thrombotic disorder",
"criterions": [
{
"exact_snippets": "history of uncontrolled thrombotic disorder",
"criterion": "thrombotic disorder",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
}
]
},
{
"line": "* Is receiving therapeutic anticoagulation with drugs",
"criterions": [
{
"exact_snippets": "receiving therapeutic anticoagulation with drugs",
"criterion": "therapeutic anticoagulation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Is receiving chronic therapy with nonsteroidal anti-inflammatory drugs",
"criterions": [
{
"exact_snippets": "receiving chronic therapy with nonsteroidal anti-inflammatory drugs",
"criterion": "chronic therapy with nonsteroidal anti-inflammatory drugs",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has a history of hemoptysis within 2 months prior to randomization",
"criterions": [
{
"exact_snippets": "history of hemoptysis within 2 months prior to randomization",
"criterion": "history of hemoptysis",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within 2 months prior to randomization"
}
]
}
]
},
{
"line": "* Has clinically relevant congestive heart failure",
"criterions": [
{
"exact_snippets": "clinically relevant congestive heart failure",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "clinical relevance",
"expected_value": true
}
]
}
]
},
{
"line": "* Has experienced any arterial thromboembolic event",
"criterions": [
{
"exact_snippets": "Has experienced any arterial thromboembolic event",
"criterion": "arterial thromboembolic event",
"requirements": [
{
"requirement_type": "experience",
"expected_value": true
}
]
}
]
},
{
"line": "* Has uncontrolled arterial hypertension",
"criterions": [
{
"exact_snippets": "uncontrolled arterial hypertension",
"criterion": "arterial hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
}
]
}
]
},
{
"line": "* Has had a serious or nonhealing wound or, ulcer",
"criterions": [
{
"exact_snippets": "serious or nonhealing wound",
"criterion": "wound",
"requirements": [
{
"requirement_type": "healing status",
"expected_value": [
"serious",
"nonhealing"
]
}
]
},
{
"exact_snippets": "ulcer",
"criterion": "ulcer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has significant existing conditions",
"criterions": [
{
"exact_snippets": "significant existing conditions",
"criterion": "existing conditions",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}